$3.54
-0.11-3.01%
Last update: Nov 10, 7:58 PM
GoodRx Holdings Inc
GDRXNASDAQ
GoodRx rose 20.5% from $3.03 to $3.65, ahead of the S&P 500's +9.8%. Its worst day was Feb 26 (−18.8%), and its low came Feb 27 at $1.87.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
GoodRx shares fell 9.4%, while the S&P 500 rose 0.5%.
−9.4% · S&P 500 +0.5%
EPS of $0.09 beat the $0.07 estimate on $194.8M revenue (est. $192.8M); FY revenue guidance of $750.0M–$780.0M against the $815.1M consensus.
Story events cover the past 12 months · Times ET
−18.8%, the year's worst day · S&P 500 −0.6%
EPS of $0.07 beat the $0.06 estimate on $194.0M revenue (est. $184.1M); FY revenue guidance of $765.0M–$785.0M against the $764.4M consensus.
+10.5% · S&P 500 −0.3%
EPS of $0.08 beat the $0.07 estimate on $200.4M revenue (est. $193.1M); FY revenue guidance of $790.0M–$805.0M against the $775.7M consensus.
+13.8% · S&P 500 −0.2%
Where it ended: a close of $3.65 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $0.07, revenue est. $202.2M).
Nothing in the past 12 months.
All GDRX dividend historyReplay the year: the line draws itself and stops at each of the 4 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GDRX and SPY from Benzinga historical bars. Not investment advice.
